130 related articles for article (PubMed ID: 12965181)
1. LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis.
Ganapathy V; Daniels T; Casiano CA
Autoimmun Rev; 2003 Sep; 2(5):290-7. PubMed ID: 12965181
[TBL] [Abstract][Full Text] [Related]
2. Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders.
Wu X; Daniels T; Molinaro C; Lilly MB; Casiano CA
Cell Death Differ; 2002 Sep; 9(9):915-25. PubMed ID: 12181742
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis.
Daniels T; Zhang J; Gutierrez I; Elliot ML; Yamada B; Heeb MJ; Sheets SM; Wu X; Casiano CA
Prostate; 2005 Jan; 62(1):14-26. PubMed ID: 15389814
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75.
Brown-Bryan TA; Leoh LS; Ganapathy V; Pacheco FJ; Mediavilla-Varela M; Filippova M; Linkhart TA; Gijsbers R; Debyser Z; Casiano CA
Mol Cancer Res; 2008 Aug; 6(8):1293-307. PubMed ID: 18708362
[TBL] [Abstract][Full Text] [Related]
5. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.
Basu A; Cajigas-Du Ross CK; Rios-Colon L; Mediavilla-Varela M; Daniels-Wells TR; Leoh LS; Rojas H; Banerjee H; Martinez SR; Acevedo-Martinez S; Casiano CA
PLoS One; 2016; 11(1):e0146549. PubMed ID: 26771192
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to lens epithelium-derived growth factor/transcription co-activator P75 (LEDGF/P75) in children with chronic nonspecific complaints and with positive antinuclear antibodies.
Kuwabara N; Itoh Y; Igarshi T; Fukunaga Y
Autoimmunity; 2009 Sep; 42(6):492-6. PubMed ID: 19657776
[TBL] [Abstract][Full Text] [Related]
7. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells.
Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
[TBL] [Abstract][Full Text] [Related]
8. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
[TBL] [Abstract][Full Text] [Related]
9. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
Huang TS; Myklebust LM; Kjarland E; Gjertsen BT; Pendino F; Bruserud Ø; Døskeland SO; Lillehaug JR
Mol Cancer; 2007 Apr; 6():31. PubMed ID: 17451600
[TBL] [Abstract][Full Text] [Related]
10. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity.
Leoh LS; van Heertum B; De Rijck J; Filippova M; Rios-Colon L; Basu A; Martinez SR; Tungteakkhun SS; Filippov V; Christ F; De Leon M; Debyser Z; Casiano CA
Mol Cancer Res; 2012 Mar; 10(3):378-91. PubMed ID: 22275515
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
Türkoğlu G; Berkem R; Karakoç AE
Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
[TBL] [Abstract][Full Text] [Related]
12. Lens epithelium-derived growth factor (LEDGF/p75) expression in fetal and adult human brain.
Chylack LT; Fu L; Mancini R; Martin-Rehrmann MD; Saunders AJ; Konopka G; Tian D; Hedley-Whyte ET; Folkerth RD; Goldstein LE
Exp Eye Res; 2004 Dec; 79(6):941-8. PubMed ID: 15642333
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us?
Ganapathy V; Casiano CA
Arthritis Rheum; 2004 Mar; 50(3):684-8. PubMed ID: 15022305
[No Abstract] [Full Text] [Related]
14. Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions.
Ortiz-Hernandez GL; Sanchez-Hernandez ES; Casiano CA
Auto Immun Highlights; 2020 Feb; 11(1):3. PubMed ID: 32127038
[TBL] [Abstract][Full Text] [Related]
15. Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
Liedtke V; Rose L; Hiemann R; Nasser A; Rödiger S; Bonaventura A; Winkler L; Sowa M; Stöckle M; Schierack P; Junker K; Roggenbuck D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047137
[TBL] [Abstract][Full Text] [Related]
16. The Structure-Specific Recognition Protein 1 Associates with Lens Epithelium-Derived Growth Factor Proteins and Modulates HIV-1 Replication.
Lopez AP; Kugelman JR; Garcia-Rivera J; Urias E; Salinas SA; Fernandez-Zapico ME; Llano M
J Mol Biol; 2016 Jul; 428(14):2814-31. PubMed ID: 27216501
[TBL] [Abstract][Full Text] [Related]
17. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity.
Wu X; Molinaro C; Johnson N; Casiano CA
Arthritis Rheum; 2001 Nov; 44(11):2642-52. PubMed ID: 11710720
[TBL] [Abstract][Full Text] [Related]
18. Identification of small peptides inhibiting the integrase-LEDGF/p75 interaction through targeting the cellular co-factor.
Cavalluzzo C; Christ F; Voet A; Sharma A; Singh BK; Zhang KY; Lescrinier E; De Maeyer M; Debyser Z; Van der Eycken E
J Pept Sci; 2013 Oct; 19(10):651-8. PubMed ID: 24014475
[TBL] [Abstract][Full Text] [Related]
19. Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
Basu A; Rojas H; Banerjee H; Cabrera IB; Perez KY; De León M; Casiano CA
PLoS One; 2012; 7(1):e30132. PubMed ID: 22276150
[TBL] [Abstract][Full Text] [Related]
20. Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
Cermáková K; Tesina P; Demeulemeester J; El Ashkar S; Méreau H; Schwaller J; Rezáčová P; Veverka V; De Rijck J
Cancer Res; 2014 Sep; 74(18):5139-51. PubMed ID: 25082813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
